TCON insider filings
Tracon Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-03-13. Screen TCON transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for TCON between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Tracon Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-03-13 | 4 | Brown Scott B. — CHIEF FINANCIAL OFFICER | Grant/award (A): 3,500 @ $0.14 · Grant/award (A): 224,800 (derivative) @ $0 | EDGAR |
| 2024-03-13 | 4 | THEUER CHARLES — PRESIDENT AND CEO, Director | Grant/award (A): 3,500 @ $0.14 · Grant/award (A): 3,500 @ $0.13 · Grant/award (A): 518,300 (derivative) @ $0 | EDGAR |
| 2023-11-14 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 4,324,008 @ $0.29 · Sale (S): 440,000 @ $0.29 | EDGAR |
| 2023-04-28 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 3,999 @ $0.66 · Purchase (P): 47,000 @ $0.75 | EDGAR |
| 2023-04-21 | 4 | Johnson-Pratt Lisa — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-04-21 | 4 | Lam Carol C. — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-04-21 | 4 | Twiford J Rainer — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-04-21 | 4 | WORLAND STEPHEN T — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-04-21 | 4 | LARUE WILLIAM R — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-04-21 | 4 | MATTINGLY MARTIN A — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-04-21 | 4 | PELLETIER SAUNDRA L — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2023-03-13 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 174,508 @ $1.38 | EDGAR |
| 2023-03-02 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 200 @ $1.52 · Purchase (P): 4,800 @ $1.52 | EDGAR |
| 2023-02-09 | 4 | Adams Bonne J. — Chief Operating Officer | Grant/award (A): 99,000 (derivative) @ $0 | EDGAR |
| 2023-02-03 | 4 | Brown Scott B. — Chief Financial Officer | Grant/award (A): 144,000 (derivative) @ $0 | EDGAR |
| 2023-02-03 | 4 | THEUER CHARLES — President and CEO, Director | Grant/award (A): 332,000 (derivative) @ $0 | EDGAR |
| 2023-01-19 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 6,800 @ $1.62 | EDGAR |
| 2023-01-19 | 4 | LARUE WILLIAM R — Director | Sale (S): 120 @ $1.26 | EDGAR |
| 2023-01-03 | 4 | Brown Scott B. — Chief Financial Officer | Purchase (P): 3,500 @ $1.49 | EDGAR |
| 2022-12-16 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 140,000 @ $1.26 · Purchase (P): 27,500 @ $1.24 | EDGAR |
| 2022-12-15 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 23,000 @ $1.29 | EDGAR |
| 2022-12-08 | 4 | Opaleye Management Inc. — 10% owner | Option exercise/expiry (X): 221,539 @ $0.01 · Sale (S): 1,539 @ $1.44 · Option exercise/expiry (X): 221,539 (derivative) @ $0.01 | EDGAR |
| 2022-11-22 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 13,900 @ $1.41 | EDGAR |
| 2022-11-04 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 9,200 @ $1.52 | EDGAR |
| 2022-11-03 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 6,000 @ $1.59 | EDGAR |
| 2022-10-19 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 10,000 @ $1.65 · Purchase (P): 2,500 @ $1.65 | EDGAR |
| 2022-10-11 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 5,000 @ $1.77 | EDGAR |
| 2022-10-05 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 5,000 @ $1.67 | EDGAR |
| 2022-10-03 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 9,400 @ $1.74 | EDGAR |
| 2022-09-28 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 1,700 @ $1.69 | EDGAR |
| 2022-09-26 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 5,000 @ $1.76 | EDGAR |
| 2022-09-22 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 3,411 @ $1.73 · Purchase (P): 13,900 @ $1.73 | EDGAR |
| 2022-09-20 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 10,000 @ $1.85 | EDGAR |
| 2022-09-19 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 5,000 @ $1.87 | EDGAR |
| 2022-09-14 | 4 | Brown Scott B. — Chief Financial Officer | Purchase (P): 2,500 @ $2.02 | EDGAR |
| 2022-07-26 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 2,254 @ $1.72 | EDGAR |
| 2022-07-25 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 4,500 @ $1.85 | EDGAR |
| 2022-07-15 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 11,826 @ $1.78 | EDGAR |
| 2022-07-14 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 7,187 @ $1.81 | EDGAR |
| 2022-07-14 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 3,000 @ $1.87 · Purchase (P): 3,000 @ $1.84 | EDGAR |
| 2022-06-27 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 11,419 @ $1.39 | EDGAR |
| 2022-06-23 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 841,989 @ $1.31 | EDGAR |
| 2022-06-16 | 4 | Twiford J Rainer — Director | Grant/award (A): 15,750 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Lam Carol C. — Director | Grant/award (A): 15,750 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Johnson-Pratt Lisa — Director | Grant/award (A): 15,750 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | WORLAND STEPHEN T — Director | Grant/award (A): 15,750 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | LARUE WILLIAM R — Director | Grant/award (A): 15,750 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | MATTINGLY MARTIN A — Director | Grant/award (A): 15,750 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | PELLETIER SAUNDRA L — Director | Grant/award (A): 15,750 (derivative) @ $0 | EDGAR |
| 2022-05-11 | 4 | THEUER CHARLES — President and CEO, Director | Purchase (P): 10,000 @ $1.85 | EDGAR |
Recent 8-K events — Tracon Pharmaceuticals, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-10-11 | 8-K | 3.02 — Unregistered Sales of Equity Securities 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-07-30 | 8-K | ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-07-16 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-07-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-06-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2024-06-12 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-13 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2024-04-12 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-04-10 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TCON returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs